control group:Glimepiride

2 trials

Sponsors

Tianjin Medical University Chu Hisen-I Memorial Hospital, Weishan People's Hospital

Conditions

DiabetesNewly diagnosed type 2 diabetes

Phase 4

Evaluation of the early renal protective effects of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus using Blood Oxygen Level-Dependent and Arterial Spin Labeling MRI

Active, not recruitingChiCTR2000037951

Tianjin Medical University Chu Hisen-I Memorial HospitalNewly diagnosed type 2 diabetes

Start: 2019-09-01Updated: 2020-11-16

To observe the effect of dapagliflozin on serum uric acid in Type 2 Diabetes Mellitus

RecruitingChiCTR2000040135

Weishan People's HospitalDiabetes

Start: 2020-12-01Updated: 2021-01-11

Related Papers

Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial.

2023-12-074 citations